• We are currently accepting research proposals for 2022. The application period is:
    5:00AM , January 6, 2022 GMT to 8:00AM , February 28, 2022 GMT.
    We look forward to receiving your proposals.
  • JP / EN


”ASAHI KASEI PHARMA OPEN INNOVATION” is an open innovation platform started in 2018 to recruit candidates for research collaborations related to drug discovery.

We aim to create innovative new drugs to match our corporate philosophy, ”contribute to life and living for people around the world”. Realizing this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.

We will accept a broad range of proposals from around the world based upon the program criteria presented in these pages. We would like to have candidates that will work together with our researchers, who are professionals in drug discovery research, to promote drug discovery research with practical applications.

“Creating for tomorrow” with you.

We sincerely look forward to receiving your research proposals.

Asahi Kasei Pharma Corporation will offer selected candidates collaborative research opportunities, with research funding and contribution to the program through our scientists’ research activities.

If the program achieves progress, we will consider a separate license agreement that includes payments such as upfront, milestones, and royalties.


  • Autoimmune Diseases
  • ACritical Care Medicine
  • Neurodegenerative Diseases
  • Pain and Neuropathy
  • Bone
  • Drug Discovery Platform Technology
  • 募集要項 ページ画像
  • よくあるご質問 ページ画像


Click “Apply” to proceed to the application form.